HIGHLIGHTS
- who: Tomomi Kimura and colleagues from the in Japan have published the paper: Quantitative Evaluation of Compliance with Recommendation for Sulfonylurea Dose Co-Administered with DPP-4 Inhibitors in Japan, in the Journal: Pharmaceutics 2012, 4, 479-493 of 11/06/2012
- what: The authors evaluated the effectiveness of risk minimization activities in Japan intended to avoid severe hypoglycemia by reducing the SU daily dose when adding a DPP-4 inhibitor.
- how: The data showed that the mean SU dose in combination therapy with a DPP-4 inhibitor before the recommendation release was . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.